Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Westphal

Showing results (271-280 of 309) with videos related to

Pageof 31
Sort By:
European Journal of Cancer (Oxford, England : 1990)|February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
International Journal of Molecular Sciences|July 2, 2021
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain MetastasisDesiree Loreth, Moritz Schuette, Jenny Zinke, et al.
Acta Neuropathologica|January 20, 2024
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastomaRichard Drexler, Robin Khatri, Ulrich Schüller, et al.
Neuro-Oncology|March 20, 2024
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection's limited influence on overall survival, ATRX as molecular prognosticatorAlice Ryba, Zeynep Özdemir, Nitzan Nissimov, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
International Journal of Cancer|March 12, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingGuido Reifenberger, Ruthild G Weber, Vera Riehmer, et al.
Journal of Extracellular Vesicles|April 6, 2019
Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumoursFranz L Ricklefs, Cecile L Maire, Rudolph Reimer, et al.
Pageof 31

Showing results (271-280 of 309) with videos related to

Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|February 25, 2021
Telomerase reverse transcriptase promoter mutation- and O<sup>6</sup>-methylguanine DNA methyltransferase promoter methylation-mediated sensitivity to temozolomide in isocitrate dehydrogenase-wild-type glioblastoma: is there a link?Dorothee Gramatzki, Jörg Felsberg, Bettina Hentschel, et al.
Journal of Neurosurgery|December 22, 2009
Poor drug distribution as a possible explanation for the results of the PRECISE trialJohn H Sampson, Gary Archer, Christoph Pedain, et al.
Journal of Neuro-Oncology|August 30, 2023
Long-term neurocognitive function and quality of life after multimodal therapy in adult glioma patients: a prospective long-term follow-upMilena Pertz, Sabine Schlömer, Clemens Seidel, et al.
International Journal of Molecular Sciences|July 2, 2021
CD74 and CD44 Expression on CTCs in Cancer Patients with Brain MetastasisDesiree Loreth, Moritz Schuette, Jenny Zinke, et al.
Acta Neuropathologica|January 20, 2024
Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastomaRichard Drexler, Robin Khatri, Ulrich Schüller, et al.
Neuro-Oncology|March 20, 2024
Insights from a multicenter study on adult H3 K27M-mutated glioma: Surgical resection's limited influence on overall survival, ATRX as molecular prognosticatorAlice Ryba, Zeynep Özdemir, Nitzan Nissimov, et al.
Oncotarget|February 20, 2016
Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO gradeMelissa Schmidt, Andreas Mock, Christine Jungk, et al.
Nature Reviews. Clinical Oncology|December 9, 2020
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthoodMichael Weller, Martin van den Bent, Matthias Preusser, et al.
International Journal of Cancer|March 12, 2014
Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profilingGuido Reifenberger, Ruthild G Weber, Vera Riehmer, et al.
Journal of Extracellular Vesicles|April 6, 2019
Imaging flow cytometry facilitates multiparametric characterization of extracellular vesicles in malignant brain tumoursFranz L Ricklefs, Cecile L Maire, Rudolph Reimer, et al.
Pageof 31